Board Member
Scilex Holding Co (SCLX)Equibles does not estimate personal net worth.
Get an email with a short summary when Scilex Holding Co publishes a filing, an earnings call transcript or a press release.
Get SCLX alertsDavid Lemus is recorded as Board Member at Scilex Holding Co (SCLX) since May 4, 2023. Scilex Holding Co reported in an 8-K filed November 29, 2024 that David Lemus resigned as Non-Executive Director, effective November 27, 2024. Scilex Holding Co reported in an 8-K filed August 31, 2023 that David Lemus resigned as Director. Scilex Holding Co reported in an 8-K filed May 5, 2023 that David Lemus was appointed Class I director, effective May 4, 2023. Equibles holds 5 filed executive changes naming David Lemus; each is listed under recent activity with its source filing. Scilex Holding Co is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Scilex Holding Co includes Henry Ji (CEO and Chairman), Jaisim Shah (CEO and Board Member), Elizabeth Czerepak (CFO) and 7 others.
“On November 27, 2024, David Lemus notified the Board of Directors (the “Board”) of Scilex Holding Company (the “Company”) that he was resigning from the Board, all committees of the Board and any director or officer position held with any subsidiary of the Company, effective as of November 27, 2024, for personal and professional reasons.”
“On August 28, 2023, each of Dorman Followwill and David Lemus notified the Board that he was resigning from the Board, all committees of the Board and any director or officer position held with any subsidiary of the Company, effective as of and contingent upon the closing of the Oramed Transaction.”
2023-05-04–present
2023-05-04–2024-11-27
SCLX
Drug Manufacturers - General · Healthcare
Board Member
2023-05-04–present
